-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

2568 Junctional Adhesion Molecule a (JAM-A) Associates with CD36 upon Platelet Activation and Cytoskeleton in a Phosphorylation-Dependent Manner to Promote Platelet-Platelet Contacts

Program: Oral and Poster Abstracts
Session: 301. Vasculature, Endothelium, Thrombosis and Platelets: Basic and Translational: Poster II
Hematology Disease Topics & Pathways:
Research, Translational Research
Sunday, December 10, 2023, 6:00 PM-8:00 PM

Sruthi Thekke Veedu, phd, Meghna U Naik, MS, John C Kostyak, PhD* and Ulhas P. Naik, PhD

Cardeza Center for Hemostasis, Thrombosis, and Vascular Biology, Cardeza Foundation for Hematologic Research, Department of Medicine, Thomas Jefferson University, Philadelphia, PA

Background: Platelets play a fundamental role in maintaining hemostasis. Stability of hemostatic plug is crucial for arresting blood loss during vascular breach. JAM-A is a member of the immunoglobulin superfamily that restricts αIIbβ3 to its low affinity state by recruiting CSK to the αIIbβ3-c-Src complex in resting platelets. Agonist-induced inside-out signaling causes JAM-A to dissociate from the αIIbβ3-Src complex, thus facilitating activation of αIIbβ3 and outside-in signaling. However, the function of JAM-A in the process of hemostasis is poorly understood.

Aim: To evaluate the role of JAM-A in activated platelets and on hemostasis.

Methods: Washed human platelets were used in these studies. Full-length cytoplasmic domain of JAM-A (cyto JAM-A) and JAM-A cytoplasmic domain lacking C-terminal PDZ-domain-binding motif (ΔPDZ cyto JAM-A) were expressed as GST-fusion proteins in bacteria using pGEX4T-1 vector. GST-fusion proteins were purified using glutathione beads. Pull-down assays were performed by incubating glutathione GST-fusion proteins beads with lysates of washed human platelets (4×108/mL). GST beads alone without the fusion proteins were used as a control. Immunoprecipitation studies were performed using washed human platelets (4x108/mL) lysed with CHAPS lysis buffer and precleared by using Protein G Sepharose beads. Specific primary antibodies and isotype specific IgGs (control) were used for immunoprecipitation followed by western blotting. To identify protein complexes two-dimensional blue-native polyacrylamide gel electrophoresis was performed in which protein complexes were first separated based on their size (1st dimension) and individual proteins in each complex were separated using SDS PAGE (2nd dimension). JAM-A S284 phosphorylation was detected using anti-Phospho-S284. Rap1 activation assay was performed by pull-down GTP-bound Rap1 following the manufacturer’s instructions.

Results: CD9 and αIIbβ3 co-immunoprecipitated with JAM-A from resting platelet lysates suggesting that CD9 is a part of the JAM-A/αIIbβ3 complex. In a pull-down assay recombinant full-length JAM-A cytoplasmic tail fused with GST, but not JAM-A tail lacking the PDZ domain motif fused with GST pull-down CD9 and αIIbβ3 from resting platelet lysates suggesting that PDZ-domain binding motif of JAM-A is responsible for its interaction with CD9/αIIbβ3 complex. Interestingly, platelet activation resulted in the dissociation of JAM-A from the CD9/αIIbβ3 complex as seen by loss of interaction between JAM-A and CD9/αIIbβ3 in co-immunoprecipitation and blue-native PAGE assays. It is reported that platelet activation results in rapid phosphorylation of JAM-A on S284 in a PKC-dependent manner. We found that S284 phosphorylated JAM-A associates with CD36 and this complex moves to the Triton X-100 insoluble cytoskeletal fraction upon platelet activation suggesting that phosphorylation of JAM-A may assist its localization to cytoskeleton. Interestingly, we found that induction of conformational change in αIIbβ3 using Mn2+ (10μM) activates JAM-A S284 phosphorylation. Furthermore, Mn2+ also induced a robust activation of Rap1, a key signaling molecule involved in junctional assembly. Both JAM-A phosphorylation and Rap1 activation were significantly (P<0.05) inhibited by a pan PKC inhibitor, bisindolylmaleimide (10μM) suggesting that S284 phosphorylated JAM-A/CD36 complex may support junctional assembly within the platelet plug.

Conclusion: JAM-A, through its cytoplasmic domain, associates with αIIbβ3 and CD9 in resting platelets. Upon platelet activation JAM-A rapidly dissociates from this complex and is phosphorylated on S284. Phosphorylated JAM-A then associates with CD36 and cytoskeleton leading to activation of Rap1, a protein important in junctional assembly between platelets within a hemostatic plug.

Disclosures: No relevant conflicts of interest to declare.

*signifies non-member of ASH